UNSPSC 51434958: Amlodipine besilate/Irbesartan

Irbesartan/amlodipine is an angiotensin-receptor blocker/calcium-channel blocker fixed-dose single-pill combination.

UNSPSC 51434958 Amlodipine besilate/Irbesartan, a Commodity code, shows minimal relevant recent activity in state and local procurement. The code nominally covers a specific pharmaceutical combination product, but the recent opportunities posted under this code do not reflect procurement for amlodipine besilate/irbesartan itself. Instead, the records include a county office relocation notice, a reverse-trade-show networking event, a vendor forum, and grant-process announcements—none of which constitute active solicitations for this or comparable pharmaceutical products. A single opportunity that appears tangentially related, the Pinellas County forensic drug standards procurement (ITQ 26-0305, Pinellas County, Florida, due April 23, 2026), sought certified reference materials for laboratory analysis, not dispensed medications. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, represents the most relevant recent activity—a multi-state cooperative contract for generic pharmaceuticals distributed across government facilities—but does not specifically name combination antihypertensive agents.

Geographic activity is scattered and episodic. Relevant pharmaceutical procurement appears in Florida (Seminole County, Pinellas County) and Arizona (Tucson Fire Department BLS/ALS supplies), while the MMCAP cooperative spans Minnesota and Oregon. No state or region shows concentrated repeat activity under this code. Business development professionals should monitor MMCAP cooperative opportunities and state health-system RFPs for generic pharmaceutical contracts, but should treat this code as low-activity for now. The mismatch between the code's nominal scope (a specific combination drug) and actual recent procurement (general pharmaceutical supplies, forensic standards, networking events) suggests either miscoding in the source data or that amlodipine besilate/irbesartan procurement does not route through state and local channels at scale during this period.